Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial (vol 11, pg 611, 2009)

被引：0
|
作者：
Jadzinsky, M.
Pfuetzner, A.
Paz-Pacheco, F.
Xu, Z.
Allen, F.
Chen, R.
机构：
来源：
DIABETES OBESITY & METABOLISM | 2010年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [1] Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
    Jadzinsky, M.
    Pfuetzner, A.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    Chen, R.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 611 - 622
  • [2] Initial combination therapy with saxagliptin and metformin improves glycaemic control compared with either monotherapy alone in drug-naive patients with type 2 diabetes
    Chen, R.
    Pfuetzner, A.
    Jadzinsky, M.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    DIABETOLOGIA, 2008, 51 : S38 - S38
  • [3] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Pfuetzner, A.
    Gurieva, I
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
  • [4] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Gurieva, I.
    Pfuetzner, A.
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 226 - 227
  • [5] Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial (vol 63, pg 1395, 2009)
    Chacra, A. R.
    Tan, G. H.
    Apanovitch, A.
    Ravichandran, S.
    List, J.
    Chen, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (02) : 277 - 277
  • [6] A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    White, Judith L.
    Buchanan, Patricia
    Li, Jia
    Frederich, Robert
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [7] A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    Judith L White
    Patricia Buchanan
    Jia Li
    Robert Frederich
    BMC Endocrine Disorders, 14
  • [8] Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)
    Lim, Soo
    Han, Kyung Ah
    Yu, JaeMyung
    Chamnan, Parinya
    Kim, Eun Sook
    Yoon, Kun-Ho
    Kwon, Sam
    Moon, Min Kyong
    Lee, Kwan Woo
    Kim, Dong-Jun
    Kim, Mikyung
    Wongtanate, Manaj
    Kim, Eun Young
    Kim, Sung-Ho
    Lee, Moon-Kyu
    DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 87 - 97
  • [9] Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients
    Marre, A
    Van Gaal, L
    Usadel, KH
    Ball, A
    Whatmough, I
    Guitard, C
    DIABETES OBESITY & METABOLISM, 2002, 4 (03): : 177 - 186
  • [10] A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
    Moses, R. G.
    Kalra, S.
    Brook, D.
    Sockler, J.
    Monyak, J.
    Visvanathan, J.
    Montanaro, M.
    Fisher, S. A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 443 - 450
12345